Radiology of rickets and osteomalacia

Vitamin D

Volumn , Issue , 2011, Pages 861-889

  Adams, Judith E ^a,b  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873989557     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-381978-9.10049-6     Document Type: Chapter

References (208)

1. Harrison H.E., Harrison H.C. Rickets then and now. J. Pediatr. 1975, 87:1144.
2. Pitt M.J. Rickets and osteomalacia are still around. Radiol. Clin. North Am. 1991, 2:9. 97-118.
3. Turner M.L., Dalinka M.K. Osteomalacia: uncommon causes. A. J. Roentgenol. 1979, 133:539-540.
4. Smerdon G.T. Daniel Whistler and the English disease. A translation and biographical note. J. Hist. Med. 1950, 5:397-415.
5. Glendening L. Source Book of Medical History 1942, Dover, New York, pp. 268-269.
6. Fourman P., Royer P. Vitamin D. Calcium Metabolism and the Bone 1960, 104-129. Oxford and Edinburgh, Blackwell.
7. Dewhurst K. Postmortem examination in case of rickets performed by John Locke. Br. Med. J. 1962, 2:1466.
8. Hunter R. Rickets, ruckets, rekets, or rackets?. Lancet 1972, 1:1176-1177.
9. LeVay D. On the derivation of the name "rickets". Proc. R. Soc. Med. 1975, 68:46-50.
10. Schutte D. Beobachtungen uber den Nutzen des Berger Leberthrans. Arch. Med. Erfahrung. 1824, 2:79-92.
11. Percival T. Observations on the medicinal uses of the oleum jecoris aselli or cod liver oil, in the chronic rheumatism and other painful disorders. Lond. Clin. Med. J. 1783, 3:392-401.
12. Palm T.A. The geographical distribution and aetiology of rickets. Practitioner 1890, 45:270-279.
13. Morse J.L. The frequency of rickets in infancy in Boston and vicinity. JAMA 1900, 34:724.
14. Parsons L.G. The bone changes occurring in renal and coeliac infantilism, and their relationship to rickets. Part I. Renal rickets. Arch. Dis. Child 1927, 2:1-25.
15. Parsons L.G. The bone changes occurring in renal and coeliac infantilism and their relationship to rickets. Part II. Coeliac rickets. Arch. Dis. Child 1927, 2:198-211.
16. G. Pommer, Untersuchungen ober osteomalacie und rachitis. Leipzig (1885).
17. Dent C.E. Rickets (and osteomalacia), nutritional and metabolic (1919-1969). Proc. R. Soc. Med. 1970, 63:401-408.
18. Hutchison F.N., Bell N.H. Osteomalacia and rickets. Semin. Nephrol. 1992, 12:127-145.
19. Berry J.L., Davies M., Mee A.P. Vitamin D metabolism, rickets, and osteomalacia. Sem. Musculoskel. Radiol. 2002, 6:173-181.
20. Pitt M.J. Rachitic and osteomalacia syndromes. Radiol. Clin. North Am. 1981, 9:581-598.
21. Smith R. The pathophysiology and management of rickets. Orthop. Clin. North Am. 1972, 3:601-621.
22. Stamp T.C., Exton-Smith A.N., Richens A. Classical rickets and osteomalacia in Britain. Lancet 1976, 2(7980):308.
23. Pettifor J.M. Vitamin D &/or calcium deficiency rickets in infants & children: a global perspective. Indian J. Med. Res. 2008, 127:245-249.
24. Stamp T.C.B., Round J.M. Seasonal changes in human plasma levels of 25-hydroxyvitamin D. Nature 1974, 247:563-565.
25. Mughal Z. Rickets in childhood. Semin. Musculoskelet. Radiol. 2002, 6:183-190.
26. Pettifor J.M. Rickets. Calcif. Tiss. Int. 2002, 70:398-399.
27. Wharton B., Bishop N. Rickets. Lancet 2003, 362:1389-1400.
28. Oestreich A.E., Ahmad B.S. The periphysis and its effect on the metaphysis. II Application to rickets and other abnormalities. Skel. Radiol. 1993, 22:115-119.
29. Steinbach H.L., Noetzli M. Roentgen appearance of the skeleton in osteomalacia and rickets. Am. J. Roentgenol. 1964, 91:955-972.
30. Ontell F.K., Moore E.H., Shephard J.A., Sheldon D.K. The costal cartilages in health and disease. Radiographics 1997, 17:571-577.
31. Thatcher T.D., Fischer P.R., Pettifor J.M., Lawson J.O., Manaster B.J. Radiographic scoring method for the assessment of the severity of nutritional rickets. J. Trop. Pediatr. 2000, 46:132-139.
32. Frankel A., Gruber B., Schey W.L. Rickets presenting as stridor and apnea. Ann. Otol. Rhinol. Laryngol. 1994, 103:905-907.
33. Glasgow J.F.T., Thomas P.S. Rachitic respiratory distress in small preterm infants. Arch. Dis. Child 1977, 52:268-273.
34. Park E.A. The influence of severe illness on rickets. Arch. Dis. Child. 1954, 29:369-380.
35. Eek S., Gabrielsen L.H., Halvosen S. Prematurity and rickets. Pediatrics 1957, 20:63-77.
36. Thandrayen K., Pettifor J.M. Maternal vitamin D status: implications for the development of infantile nutritional rickets. Endocrinol. Metab. Clin. North Am. 2010, 39:303-320.
37. Pettifor J.M., Pentopoulos M., Moodley G.P., Isdale J.M., Ross F.P. Is craniotabes a pathognomonic sign of rickets in a 3-month-old infants?. S. Afr. Med. J. 1984, 65:549-551.
38. Harris H.A. Rickets. Bone Growth in Health and Disease 1933, 87. Oxford Medical Publications, Oxford University Press, London.
39. Land C., Rauch F., Glorieux F.H. Cyclical intravenous pamidronate treatment affects metaphyseal modeling in growing patients with osteogenesis imperfecta. J. Bone Miner. Res. 2006, 21:374-379.
40. Davies D.R., Dent C.E., Willcox A. Hyperparathyroidism and steatorrhoea. B. Med. J. 1956, 2:1133-1137.
41. Mankin H.J. Rickets, osteomalacia, and renal osteodystrophy - Part I. J. Bone Joint Surg. (Am.) 1974, 56:101-128.
42. Mankin H.J. Rickets, osteomalacia, and renal osteodystrophy - Part II. J. Bone Joint Surg. (Am.) 1974, 56:352-386.
43. Mankin H.J. Rickets, osteomalacia, and renal osteodystrophy. Orthop. Clin. North Am. 1990, 21:81-96.
44. Bereket A., Casyr Y., Firat P., Yordam N. Brown tumor as a complication of secondary hyperparathyroidism in severe long lasting vitamin-D deficiency rickets. Eur. J. Paediatr. 2000, 159:70-73.
45. Looser E. Uber spatrachitis und die Beziehungen zwischen rachitis und osteomalacie. Mitt. Grenzgeb. Med. Chir. 1908, 18:678-744.
46. Looser E. Uber spatrachitis und osteomalacie Klinishe ront-genologische und pathologischanatomische Untersuchungen. Drsch. Z. Chir. 1920, 152:210-357.
47. Looser E. Uber pathologische Formen von Infraktionen und Callusbildungen bei Rachitis und osteomalakie und anderen knocken Erkrankungen. Zbl. Chir. 1920, 47:1470-1474.
48. Milkman L.A. Pseudofractures (hunger osteopathy, late rickets, osteomalacia). Am. J. Roentgenol. 1930, 24:29-37.
49. Milkman L.A. Multiple spontaneous idiopathic symmetrical fracture. Am. J. Roentgenol. 1934, 32:622-634.
50. Reginato A.J., Falasca G.F., Pappu R., McKnight B., Agha A. Musculoskeletal manifestations of osteomalacia: report of 26 cases and literature review. Semin. Arthrit. Rheum. 1999, 28:287-303.
51. Camp J.D., McCullough J.A.L. Pseudofractures in diseases affecting the skeletal system. Radiology 1941, 36:651-661.
52. LeMay M., Blunt J.W. A factor determining the location of pseudofractures in osteomalacia. J. Clin. Invest. 1949, 28:521-525.
53. Steinbach H.L., Kolb F.O., Gilfillan R. A mechanism of the production of pseudofractures in osteomalacia (Milkman's syndrome). Radiology 1954, 62:388-394.
54. Cooper K.L. Insufficiency stress fractures. Curr. Prob. Diagn. Radiol. 1994, 23:29-68.
55. McKenna M.J., Kleerekoper M., Ellis B.I., Rao D.S., Parfitt A.M., Frame B. Atypical insufficiency fractures confused with Looser zones of osteomalacia. Bone 1987, 8:71-78.
56. North K.A.K. Multiple stress fractures simulating osteomalacia. Am. J. Roentgenol. 1966, 97:672-675.
57. Quek S.T., Peh W.C.G. Radiology of osteoporosis. Semin. Musculoskelet. Radiol. 2002, 6:197-206.
58. Whitehouse R.W. Paget's disease of bone. Semin. Musculoskeletal Radiol. 2002, 6:313-322.
59. Resnick D.L. Fish vertebrae. Arthritis Rheum. 1982, 25:1073-1077.
60. Pitt M.J. Rickets and osteomalacia. Diagnosis of Bone and Joint Disorders 1995, 1885-1920. Saunders, Philadelphia, Pennsylvania. D. Resnick (Ed.).
61. Shapiro R. Radiologic aspects of renal osteodystrophy. Radiol. Clin. North Am. 1972, 10:557-568.
62. Sundaram M. Renal osteodystrophy. Skeletal Radiol. 1989, 18:415-426.
63. Adams J.E. Dialysis bone disease. Semin. Dial. 2002, 15:277-289.
64. Sundaram M. Founders lecture 2007: metabolic bone disease: what has changed in 30 years?. Skeletal. Radiol. 2009, 38:841-853.
65. McCarthy J.T., Kumar R. Behavior of the vitamin D endocrine system in the development of renal osteodystrophy. Semin. Nephrol. 1986, 6:21-30.
66. Peacock M. Renal bone disease. Practitioner 1978, 220:913-918.
67. Massry S.G., Ritz E. The pathogenesis of secondary hyperparathyroidism of renal failure: is there a controversy?. Arch. Intern. Med. 1978, 138:853-856.
68. Norfray J., Calenoff L., DelGreco F., Krumlovsky F. Renal osteodystrophy in patients on hemodialysis as reflected in the bony pelvis. Am. J. Roentgenol. 1975, 25:352-358.
69. Parfitt A.M. Renal osteodystrophy. Orthop. Clin. North Am. 1972, 3:681-698.
70. Theodorou D.J., Theodorou S.J., Resnich D. Imaging in dialysis spondyloarthropathy. Semin. Dial. 2002, 15:290-296.
71. Applbaum Y.H. Imaging of the skeleton and the joints in CKD. The spectrum of mineral and bone disorders in chronic kidney disease 2010, 199-216. Oxford University Press. K. Olgaard, I.B. Salusky, J. Silver (Eds.).
72. Bardin T. Dialysis-associated amyloidosis. The spectrum of mineral and bone disorders in chronic kidney disease 2010, 267-281. Oxford University Press. K. Olgaard, I.B. Salusky, J. Silver (Eds.).
73. Resnick D., Niwayama G. Subchondral resorption of bone in renal osteodystrophy. Radiology 1976, 118:315-321.
74. Andresen J., Nielsen H.E. Juxta-articular erosions and calcifications in patients with chronic renal failure. Acta Radiol. Diagn. (Stockh.) 1981, 22:709-713.
75. Tigges S., Nance E.P., Carpenter W.A., Erb R. renal osteodystrophy: imaging findings that mimic those of other diseases. Am. J. Roentgenol. 1995, 165:143-148.
76. Resnick D.L. Erosive arthritis of the hand and wrist in hyperparathyroidism. Radiology 1974, 110:263-269.
77. Goldman A.B., Lane J.M., Salvati E. Slipped capital femoral epiphyses complicating renal osteodystrophy: a report of three cases. Radiology 1978, 126:333-339.
78. Mehls O., Ritz E., Krempien B., Gilli G., Link K., Willich E., et al. Slipped epiphyses in renal osteodystrophy. Arch. Dis. Child. 1975, 50:545-554.
79. Wolf H.L., Deubo J.V. Osteosclerosis in chronic renal disease. Am. J. Med. Sci. 1958, 235:33-42.
80. Bellorin-Font E., Adams J.E., Cunningham J. Osteopenia in uremai. The spectrum of mineral and bone disorders in chronic kidney disease 2010, 235-251. Silver J. Oxford University Press. K. Olgaard, I.R. Salusky (Eds.).
81. Meema H.E., Oreopoulos D.G., Rabinovich S., Husdan H., Rapoport A. Periosteal new bone formation (periosteal neostosis) in renal osteodystrophy. Radiology 1974, 110:513-522.
82. Ritchie W.G., Winney R.J., Davison A.M., Robson J.S. Periosteal new bone formation developing during haemodialysis for chronic renal failure. Br. J. Radiol. 1975, 48:656-661.
83. Slatopolsky E., Rutherford W.E., Hruska K., Martin K., Klahr S. How important is phosphate in the pathogenesis of renal osteodystrophy?. Arch. Intern. Med. 1978, 138:848-852.
84. Parfitt A.M. Soft-tissue calcification in uremia. Arch. Intern. Med. 1969, 124:544-556.
85. Zisman A.L., Wolf M. Recent advances in the rapidly evolving field of fibroblast growth factor 23 in chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 2010, 19:335-342.
86. Gutiérrez O.M., Mannstadt M., Isakova T., Rauh-Hain J.A., Tamez H., Shah A., et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N. Engl. J. Med. 2008, 359(6):584-592.
87. Jüppner H., Wolf M., Salusky I.B. FGF-23: more than a regulator of renal phosphate handling?. J. Bone Miner. Res. 2010, 25:2091-2097.
88. Kuro-o M. Overview of the FGF23-Klotho axis. Pediatr. Nephrol. 2010, 25:583-590.
89. Gipstein R.M., Coburn J.W., Adams D.A., Lee D.B., Parsa K.P., Sellars A., et al. Caliciphylaxis in man: a syndrome of tissue necrosis and vascular calcification in patients with chronic renal failure. Arch. Intern. Med. 1976, 136:1273-1280.
90. Weenig R.H., Sewell L.D., Davis M.D., McCarthy J.T., Pittelkow M.R. Calciphylaxis: natural history, risk factor analysis, and outcome. J. Am. Acad. Dermatol. 2007, 56:569-579.
91. Weinreich T. Prevention of renal osteodystrophy in peritoneal dialysis. Kidney Int. 1998, 54:2226-2233.
92. Musci I., Hercz G. Adynamic bone disease: pathogenesis, diagnosis, and clinical relevance. Curr. Opin. Nephrol. Hyperten. 1977, 6:356-361.
93. Frazão J.M., Martins P. Adynamic bone disease: clinical and therapeutic implications. Curr. Opin. Nephrol. Hypertens. 2009, 18:303-307.
94. Tonelli M., Pannu N., Manns B. Oral phosphate binders in patients with kidney failure. N. Engl. J. Med. 2010, 362:1312-1324.
95. Dellegrottaglie S., Saran R., Rajagopalan S. Vascular calcification in patients with renal failure: culprit or innocent bystander?. Cardiol. Clin. 2005, 23:373-384.
96. Abedi S.A., Tarzamni M.K., Nakhjavani M.R., Bohlooli A. Effect of renal transplantation on coronary artery calcification in hemodialysis patients. Transplant. Proc. 2009, 41:2829-2831.
97. Verberckmoes R., Bouillon R., Krempien B. Disappearance of vascular calcification during treatment of renal osteodystrophy - two patients treated with high doses of vitamin D and aluminium hydroxide. Ann. Intern. Med. 1975, 82:529-533.
98. Raggi P. Effects of excess calcium load on the cardiovascular system measured by electron beam tomography in endstage renal failure. Nephrol. Dial. Transplant. 2002, 17:332-335.
99. Raggi P., Boulay A., Chasan-Tabar S., Amin N., Dillon M., Burke S.K., et al. Cardiac calcification in adult hemodialsis patients. A link between end-stage renal disease and cardiovascular disease. J. Am. Coll. Cadio. 2002, 20:695-701.
100. Bellasi A., Ferramosca E., Muntner P., Ratti C., Wildman R.P., Block G.A., et al. Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients. Kidney Int. 2006, 70:1623-1628.
101. Raggi P., London G.M. Non-invasive assessment of vascular calcification and arterial stiffness. The spectrum of mineral and bone disorders in chronic kidney disease 2010, 217-234. Oxford University Press. K. Olgaard, I.B. Salusky, J. Silver (Eds.).
102. Schousboe J.T., Claflin D., Barrett-Connor E. Association of coronary aortic calcium with abdominal aortic calcium detected on lateral dual energy x-ray absorptiometry spine images. Am. J. Cardiol. 2009, 104:299-304.
103. Bolland M.J., Wang T.K., van Pelt N.C., Horne A.M., Mason B.H., Ames R.W., et al. Abdominal aortic calcification on vertebral morphometry images predicts incident myocardial infarction. J. Bone Miner. Res. 2010, 25:505-512.
104. Isgum I., van Ginneken B., Olree M. Automatic detection of calcifications in the aorta from CT scans of the abdomen. 3D computer-aided diagnosis. Acad. Radiol. 2004, 11:247-257.
105. Kauppila L.I., Polak J.F., Cupples L.A., Hannan M.T., Kiel D.P., Wilson P.W. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 1997, 132:245-250.
106. Schousboe J.T., Taylor B.C., Kiel D.P., Ensrud K.E., Wilson K.E., McCloskey E.V. Abdominal aortic calcification detected on lateral spine images from a bone densitometer predicts incident myocardial infarction or stroke in older women. J. Bone Miner. Res. 2008, 23:409-416.
107. Andress D.L., Maloney N.A., Coburn J.W., Endres D.B., Sherrard D.J. Osteomalacia and aplastic bone disease in aluminum-related osteodystrophy. J. Clin. Endocrinol. Metab. 1987, 65:11-16.
108. Kriegshauser J.S., Swee R.G., McCarthy J.T., Hauser M.F. Aluminium toxicity in patients undergoing dialysis: radiographic findings and prediction of bone biopsy results. Radiology 1987, 164:399-403.
109. Ward M.K., Feest T.G., Ellis H.A., Parkinson I.S., Kerr D.N.S. Osteomalacic dialysis osteodystrophy: evidence for a water-borne aetiological agent, probably aluminum. Lancet 1978, 1(8069):841-8455.
110. Smith G.D., Winney R.J., McLean A., Robson J.S. Aluminum-related osteomalacia: response to reverse osmosis water treatment. Kidney Int. 1987, 32:96-101.
111. Sundaram M., Dessner D., Ballal S. Solitary spontaneous cervical and large bone fracture in aluminum osteodystrophy. Skel. Radiol. 1991, 20:91-94.
112. Bover J., Aguilar A., Baas J., Reyes J., Lloret M.J., Farré N., et al. Calcimimetics in the chronic kidney disease-mineral and bone disorder. Int. J. Artif. Organs 2009, 32:108-121.
113. Schulman J.D., Schneider J.A. Cystinosis and the Fanconi syndrome. Pediatr. Clin. North Am. 1976, 23:779-793.
114. Dubois J., Garel L., Patriquin H., Paradis K., Forget S., Filiatrault D., et al. Imaging features of Type 1 hereditary tyrosinemia: a review of 30 patients. Pediatr. Radiol. 1996, 26:845-851.
115. Takebayashi S., Jimi S., Segawa M., Kiyoshi Y. Cadmium induces osteomalacia mediated by proximal tubular atrophy and disturbance of phosphate resorption. A study of 11 autopsies. Pathol. Res. Pract. 2000, 196:653-663.
116. Lawson J. Drug-induced metabolic bone disorders. Semin. Musculoskelet. Radiol. 2002, 6:285-297.
117. Ryan E.A., Reiss E. Oncogenous osteomalacia: review of the world literature of 42 cases. Am. J. Med. 1984, 77:501-512.
118. Clarke B.L., Wynne A.G., Wilson D.M., Fitzpatrick L.A. Osteomalacia associated with adult Fanconi's syndrome: clinical and diagnostic features. Clin. Endocrinol. 1995, 43:479-490.
119. Olivares J.L., Ramos F.J., Carapeto F.J., Bueno M. Epidermal naevus syndrome and hypophosphatemic rickets: description of a patient with central system anomalies and a review of the literature. Eur. J. Pediatr. 1999, 158:103-107.
120. Econs M.J., McEnery P.T. Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder. J. Clin. Endocrinol. Metab. 1997, 82:674-681.
121. Hanna J.D., Niimi K., Chan J.C.M. X-linked hypophosphatemia. Genetic and clinical correlates. Am. J. Dis. Child 1991, 145:865-870.
122. Walton J. Familial hypophosphatemic rickets: a delineation of its subdivisions and pathogenesis. Clin. Pediatr. 1976, 15:1007-1012.
123. Weisman Y., Hochberg Z. Genetic rickets and osteomalacia. Curr. Ther. Endocrinol. Metab. 1994, 5:492-495.
124. Rowe P.S. The role of the PHEX (PEX) gene in families with X-linked hypophosphatemic rickets. Curr. Opin. Nephrol. Hypertens. 1998, 7:367-376.
125. Rowe P.S. The wrickkened pathways of FGF23, MEPE and PHEX. Crit. Rev. Oral Biol. Med. 2004, 15:264-281.
126. Strewler G.J. FGF23, hypophosphatemia, and rickets: has phosphatonin been found?. Proc. Natl. Acad. Sci. USA 2001, 98:5945-5946.
127. Bastepe M., Jüppner H. Inherited hypophosphatemic disorders in children and the evolving mechanisms of phosphate regulation. Rev. Endocr. Metab. Disord. 2008, 9:171-180.
128. Gattineni J., Baum M. Regulation of phosphate transport by fibroblast growth factor 23 (FGF23): implications for disorders of phosphate metabolism. Pediatr. Nephrol. 2010, 25:591-601.
129. Sullivan W., Carpenter T., Glorieux F., Travers R., Insogna K. A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X linked hypophosphatemic rickets. J. Clin. Endocrinol. Metab. 1992, 75:879-885.
130. Milgram J.W., Compere C.L. Hypophosphatemic vitamin D refractory osteomalacia with bilateral femoral pseudofractures. Clin. Orthop. 1981, 160:78-85.
131. Rivkees S.A., el-Hajj-Fuleihan G., Brown E.M., Crawford J.D. Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets. J. Clin. Endocrinol. Metab. 1992, 76:1514-1518.
132. Steinbach H.L., Kolb F.O., Crane J.T. Unusual Roentgen manifestations of osteomalacia. Am. J. Roentgenol. 1959, 82:875-886.
133. O'Malley S.P., Adams J.E., Davies M., Ramsden R.T. The petrous temporal bone and deafness in X-linked hypophosphatemic osteomalacia. Clin. Radiol. 1988, 39:528-530.
134. Kuether T.A., Piatt J.H. Chiari malformation associated with vitamin D-resistant rickets: case report. Neurosurgery 1998, 42:1168-1171.
135. Caldermeyer K.S., Boaz J.C., Wappner R.S., Moran C.C., Smith R.R., Quets J.P. Chiari 1 malformation: association with hypophosphatemic rickets and MR imaging appearances. Radiology 1995, 195:733-738.
136. McAlister W.H., Kim G.S., Whyte M.P. Tibial bowing exacerbated by partial premature epiphyseal closure in sex-linked hypophosphatemic rickets. Radiology 1987, 162:461-463.
137. Burnstein M.I., Lawson J.P., Kottamasu S.R., Ellis B.I., Micho J. The enthesopathic changes of hypophosphatemic osteomalacia in adults: radiologic findings. Am. J. Roentgenol. 1989, 153:785-790.
138. Polisson R.P., Martinez S., Khoury M., Harrell R.M., Lyles K.W., Friedman N., et al. Calcification of entheses associated with X-linked hypophosphatemic osteomalacia. N. Engl. J. Med. 1985, 313:1-6.
139. Cartwright D.W., Latham S.C., Masel J.P., Yelland J.D.N. Spinal canal stenosis in adults with hypophosphatemic vitamin D-resistant rickets. Aust. New Zealand J. Med. 1979, 9:705-708.
140. Adams J.E., Davies M. Intra-spinal new bone formation and spinal cord compression in familial hypophosphataemic vitamin D resistant osteomalacia. Q. J. Med. 1986, 61:1117-1129.
141. Dunlop D.J., Stirling A.J. Thoracic cord compression caused by hypophosphatemic rickets: a case report and a review of the world literature. Eur. Spine J. 1996, 5:272-274.
142. Hardy D.C., Murphy W.A., Siegel B.A., Reid I.R., Whyte M.P. X-linked hypophosphatemia in adults: prevalence of skeletal radiographic and scintigraphic features. Radiology 1989, 171:403-414.
143. Econs M.J., Samsa G.P., Monger M., Drezner M.L., Fuessner J.R. X-linked hypophosphatemic rickets: a disease often unknown to affected patients. Bone Miner. 1994, 24:17-24.
144. Prader A., Illig R., Uehlinger R.E. Rachitis infolge Knochen-tumors. Helv. Paediatr. Acta 1959, 14:554-565.
145. Sundaram M., McCarthy E.F. Oncogenic osteomalacia. Skeletal Radiol. 2000, 29:117-124.
146. Ward L.M. Renal phosphate - wasting disorders in childhood. Pediatr. Endocrinol. Rev. 2005, 2(Suppl. 3):342-350.
147. Shaikh A., Berndt T., Kumar R. Regulation of phosphate homeostasis by the phosphatonins and other novel mediators. Pediatr. Nephrol. 2008, 23:1203-1210.
148. Chouhan V., Agrawal K., Vinothkumar T.K., Mathesul A. Bilateral insufficiency fracture of the femoral head and neck in a case of oncogenic osteomalacia. J. Bone Joint Surg. Br. 2010, 92:1028-1031.
149. Ohashi K., Ohnishi T., Ishikawa T., Tani H., Uesugi K., Takagi M. Oncogenic osteomalacia presenting as bilateral stress fractures of the tibia. Skeletal Radiol. 1999, 28:46-48.
150. Wilkins G.E., Granleese S., Hegele R.G., Holden J., Anderson D.W., Bond G.P. Oncogenic osteomalacia: evidence for a humeral phosphaturic factor. J. Clin. Endocrinol. Metab. 1995, 80:1628-1634.
151. John M.R., Wickert H., Zaar K., Jonsson K.B., Grauer A., Puppersberger P., et al. A case of neuroendocrine oncogenic osteomalacia associated with a PHEX and fibroblast growth factor-23 expressing sinusoidal malignant schwannoma. Bone 2001, 29:393-402.
152. Jüppner H. Novel regulators of phosphate homeostasis and bone metabolism. Ther. Apher. Dial. 2007, 11(Suppl. 1):S3-22.
153. Renton P., Shaw D.G. Hypophosphatemic osteomalacia secondary to vascular tumors of bone and soft tissue. Skeletal Radiol. 1976, 1:21-24.
154. Choi J.J., Murphey M.D. Angiomatous skeletal lesions. Semin. Musculoskel. Radiol. 2000, 4:103-112.
155. Taylor H.C., Fallen M.D., Velasco M.E. Oncogenic osteomalacia and inappropriate antidiuretic hormone secretion due to oat-cell carcinoma. Ann. Intern. Med. 1984, 101:786-788.
156. Kenealy H., Holdaway I., Grey A. Occult nasal sinus tumours causing oncogenic osteomalacia. Eur. J. Intern. Med. 2008, 19:516-519.
157. Savage C.R., Zimmer L.A. Oncogenic osteomalacia from pterygopalatine fossa mass. J. Laryngol. Otol. 2009, 123:1052-1054.
158. Folpe A.L., Fanburg-Smith J.C., Billings S.D., Bisceglia M., Bertoni F., Cho J.Y., et al. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am. J. Surg. Pathol. 2004, 28:1-30.
159. Pollack J.A., Schiller A.L., Crawford J.D. Rickets and myopathy cured by removal of a nonossifying fibroma of bone. Pediatrics 1973, 52:363-371.
160. Linovitz R.J., Resnick D., Keissling P., Kondon J.J., Sehler B., Nejdl R.J., et al. Tumor-induced osteomalacia and rickets: a surgically curable syndrome, report of two cases. J. Bone Joint Surg. (Am.) 1976, 58:419-423.
161. Ward L.M., Rauch F., White K.E., Filler G., Matzinger M.A., Letts M., et al. Resolution of severe, adolescent-onset hypophosphatemic rickets following resection of an FGF-23-producing tumour of the distal ulna. Bone 2004, 34:905-911.
162. Radaideh A.R., Jaradat D., Abu-Kalaf M.M., Nusier M.K. Resolution of severe oncogenic hypophosphatemic osteomalacia after resection of a deeply located soft tissue tumour. Curr. Oncol. 2007, 16:87-90.
163. Leicht E., Kramann B., Seitz G., Trentz O., Remberger K. Oncogenic osteomalacia: Imaging studies. Bildgebung. 1993, 60:13-17.
164. Shapiro D., Ben Izhak O., Nachtigal A., Burstein A., Shalom R.B., Shagrawi I., et al. Tumour induced osteomalacia. Semin. Arthritis Rheum. 1995, 25:35-46.
165. Avila N.A., Skarulois M., Rubino D.M., Doppman J.L. Oncogenic osteomalacia: lesion detected by MR skeletal survey. Am. J. Roentgenol. 1996, 167:343-345.
166. Rhee Y., Lee J.D., Shin K.H., Lee H.C., Huh K.B., Lim S.K. Oncogenic osteomalacia associated with mesenchymal tumour detectd by indium-111 ocreotide scintigraphy. Clin. Endocrinol. 2001, 54:551-554.
167. Edminster K.A., Sundaram M. Oncogenic osteomalacia. Semin. Musculoskel. Radiol. 2002, 6:191-196.
168. Streeten E.A., Civelek A.C., McCarthy E.F., Uribe L., Marx S.J., Onobrakpeya O., et al. Localisation of mesenchymal tumours by somatostatin receptor imaging. Lancet 2002, 359(9308):761-763.
169. Hesse E., Moessinger E., Rosenthal H., Laenger F., Brabant G., Petrich T., et al. Oncogenic osteomalacia: exact tumor localization by co-registration of positron emission and computed tomography. J. Bone Miner. Res. 2007, 22:158-162.
170. von Falck C., Rodt T., Rosenthal H., Länger F., Goesling T., Knapp W.H., et al. (68)Ga-DOTANOC PET/CT for the detection of a mesenchymal tumor causing oncogenic osteomalacia. Eur. J. Nucl. Med. Mol. Imaging 2008, 35:1034.
171. Müssig K., Oksüz M.O., Pfannenberg C., Adam P., Zustin J., Beckert S., et al. Somatostatin receptor expression in an epitheloid hemangioma causing oncogenic osteomalacia. J. Clin. Endocrinol. Metab. 2009, 94:4123-4124.
172. Whyte M.P., Podgornik M.N., Wollberg V.A., Eddy M.C., McAlister W.H. Pseudo-(tumor-induced) rickets. J. Bone Miner. Res. 2001, 16:1564-1571.
173. Salahudeen A.K., Elliott R.W., Ellis H.A. Osteomalacia due to ileal replacement of ureters: a report of 2 cases. J. Urol. 1984, 131:335-337.
174. Boutsen Y., Devogelaer J.P., Malghem J., Noel H., Nagant de Deuxchais C. Antacid-induced osteomalacia. Clin. Rheumatol. 1996, 15:75-80.
175. Kassem M., Eriksen E.F., Melsen F., Mosekilde L. Antacid-induced osteomalacia; a case report with a histomorphometric analysis. J. Intern. Med. 1999, 229:275-279.
176. Berrocal T., Simon M.J., al-Assir I., Prieto C., Pastor I., de Pablo L., et al. Shwachman-Diamond syndrome: clinical, radio9logical and sonographic aspects. Pediatr. Radiol. 1995, 25:289-292.
177. Cohen M.M. Some chondrodysplasias with short limbs: molecular perspectives. Am. J. Med. Genet. 2002, 112:304-313.
178. Cohen M.M. Merging the old skeletal biology with the new. II. Molecular aspects of bone formation and growth. J. Craniofac. Genet. Dev. Biol. 2000, 20:94-106.
179. Vohra P. metaphyseal chondrodysplasia: a differential diagnosis of rickets. Indian J. Pediatr. 1995, 62:131-132.
180. Rathbun J.C., MacDonald J.W., Robinson H.M.C., Wanklin J.M. Hypophosphatasia: a genetic study. Arch. Dis. Child 1961, 36:540-542.
181. Wendling D., Jeannin-Louys L., Kremer P., Fellmann F., Toussirot E., Mornet E. Adult hypophosphatasia. Current concepts. Joint Bone Spine 2001, 68:120-124.
182. Davies M., Adams P.H. The continuing risk of vitamin-D intoxication. Lancet 1978, 16:621-623.
183. Anning S.T., Dawson J., Dolby D.E., Ingram J.T. The toxic effects of calciferol. Q. J. Med. 1948, 17:203-228.
184. Harris P.W.R. An unusual case of calcinosis due to vitamin D intoxication. Guy's Hospital Rev. 1969, 118. 553-541.
185. Irnell L. Metastatic calcification of soft tissue on overdosage of vitamin D. Acta Med. Scand. 1969, 185:147-152.
186. Cowen A.R., Davies A.G., Kengyelics S.M. Advances in computed radiography systems and their physical imaging characteristics. Clin. Radiol. 2007, 62:1132-1141.
187. Alazraki N. Radionuclide techniques. Diagnosis of Bone and Joint Disorders 1995, 430-474. Saunders, Philadelphia, Pennsylvania. D. Resnjck (Ed.).
188. Murray I.P.C. Nuclear medicine in disorders of bone and joints: growth and metabolic disorders. Nuclear Medicine in Clinical Diagnosis and Treatment 1994, 1035-1040. Churchill Livingstone, London. I.P.C. Murray, P.J. Ell (Eds.).
189. Lee H.K., Sung W.W., Solodnik P., Shimshi M. Bone scan in tumor-induced osteomalacia. J. Nucl. Med. 1995, 36:247-249.
190. 99mTc-labelled phosphate complex uptake in metabolic bone disease. Semin. Nucl. Med. 1976, 6:59-67.
191. Hain S.F., Fogelman I. Nuclear medicine studies in metabolic bone disease. Semin. Musculoskel. Radiol. 2002, 6:323-329.
192. Mari C., Catafau A., Carrio I. Bone scintigraphy and metabolic disorders. Q. J. Nucl. Med. 1999, 43:259-267.
193. McAfee J.G. Radionuclide imaging in metabolic and systemic skeletal diseases. Semin. Nucl. Med. 1987, 17:334-349.
194. Singh B.N., Spies S.M., Mehta S.P., Kesala B.A., Quinn J.L. Unusual bone scan presentation of osteomalacia: symmetrical uptake - a suggestive sign. Clin. Nucl. Med. 1978, 3:292-295.
195. Wu Y.W., Seto H., Shimizu M., Kageyama M., Watanabe N., Kakishita M. Postgastrectomy osteomalacia with pseudofractures assessed by repeated bone scintigraphy. Ann. Nucl. Med. 1995, 9:29-32.
196. Meindok H., Rapoport A., Oreopoulos D.G., Rabinovich S., Meema H.E., Meema S. Quantitative radionuclide scanning in metabolic bone disease. Nucl. Med. Commun. 1985, 6:141-148.
197. Nguyen B.D., Wang E.A. Indium-111 pentetreotide scintigraphy of mesenchymal tumour with oncogenic osteomalacia. Clin. Nucl. Med. 1999, 24:130-131.
198. Jan de Beur S.M., Streeten E.A., Civelek A.C., McCarthy E.F., Uribe L., Marx S.J., et al. Localisation of mesenchymal tumours by somatostatin receptor imaging. Lancet 2002, 359:761-763.
199. Moran M., Paul A. Ocreotide scanning in the detection of a mesenchymal tumor in the pubic symphysis causing hypophosphatemic osteomalacia. Int. Orthop. 2002, 26:61-62.
200. Fukumoto S., Takeuchi Y., Nagano A., Fujita T. Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia. Bone 1999, 25:375-377.
201. Adams J.E. Dual Energy X-ray Absorptiometry. Radiology of osteoporosis 2008, 105-124. Springer, Berlin Heidelberg. second ed. S. Grampp (Ed.).
202. J.E. Adams, N. Bishop, Dual energy X-ray absorptiometry (DXA) in adults and children. In: American Society of Bone and Mineral Research (ASBMR) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, seventh ed.; Editor: C. Rosen 2009 pp 152-158.
203. Blake G.M., Fogelman I. Dual energy X-ray absorptiometry and its clinical applications. Semin. Musculoskel. Radiol. 2002, 6:207-217.
204. Guglielmi G., Lang T.F. Quantitative tomography. Semin. Musculoskel. Radiol. 2002, 6:219-227.
205. Engelke K., Adams J.E., Armbrecht G., Augat P., Bogado C.E., Bouxsein M.L., et al. Clinical Use of Quantitative Computed Tomography and Peripheral Quantitative Computed Tomography in the Management of Osteoporosis in Adults: The 2007 ISCD Official Positions. J. Clin. Densitom. 2008, 11:123-162.
206. Adams J. Quantitative computed tomography. Europ. J. Radiol. 2009, 71:415-424.
207. Wishart J., Horowitz M., Need A., Nordin B.E. Relationship between forearm and vertebral mineral density in postmenopausal women with primary hyperparathyroidism. Arch. Intern. Med. 1990, 150:1329-1331.
208. Selby P.L., Davies M., Adams J.E., Mawer E.B. Bone loss in celiac disease is related to secondary hyperparathyroidism. J. Bone Miner. Res. 1999, 14:652-657.